Author Title Type [ Year(Asc)]
Filters: Author is Nagler, Arnon  [Clear All Filters]
Kröger, N., Solano, C., Wolschke, C., Bandini, G., Patriarca, F., Pini, M., Nagler, A., Selleri, C., Risitano, A., Messina, G., et al. (2016). Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.N Engl J Med374, 43-53.
Orlowski, R.Z., Nagler, A., Sonneveld, P., Bladé, J., Hajek, R., Spencer, A., Robak, T., Dmoszynska, A., Horvath, N., Spicka, I., et al. (2016). Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma.Cancer.
Czerw, T., Labopin, M., Schmid, C., Cornelissen, J.J., Chevallier, P., Blaise, D., Kuball, J., Vigouroux, S., Garban, F., Lioure, B., et al. (2016). High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelate.Oncotarget.
Byrne, M., Savani, B.N., Mohty, M., and Nagler, A. (2016). Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Exp Hematol.
Ruggeri, A., Battipaglia, G., Labopin, M., Ehninger, G., Beelen, D., Tischer, J., Ganser, A., Schwerdtfeger, R., Glass, B., Finke, J., et al. (2016). Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study.J Hematol Oncol9, 89.
Giebel, S., Czyż, A., Ottmann, O., Baron, F., Brissot, E., Ciceri, F., Cornelissen, J.J., Esteve, J., Gorin, N.-C., Savani, B., et al. (2016). Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the acute leukemia working party of the .Cancer.